Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Cassava Sciences Inc
SAVACurrent price
30.32 USD
-1.47 USD (-4.62%)
Last closed
31.3 USD
Company
www.cassavasciences.com
ISIN
US14817C1071
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 349 090 816 USD
Yield for 12 month
+63.98 %
1Y
3Y
5Y
10Y
15Y
SAVA
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas. Address: 6801 N. Capital of Texas Highway, Austin, TX, United States, 78731
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
103 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
-1 800 USD
Current Quarter
–
Last Quarter
–
Current Year
-1 530 000 USD
Last Year
-1 800 USD
Current Quarter
-300 000 USD
Last Quarter
-311 000 USD
Key Figures SAVA
1 year
3 years
5 years
10 years
EBITDA
-130 643 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-37.43 %
PEG Ratio
–
Return On Equity TTM
-8.35 %
Wall Street Target Price
103 USD
Revenue TTM
–
Book Value
3.94 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-68 032 000 USD
Earnings per share
-2.83 USD
Diluted Eps TTM
-2.83 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics SAVA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SAVA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
13.12.2012
Forward Annual Dividend Yield
–
Last Split Factor
1:7
Payout Ratio
–
Last Split Date
10.05.2017
Dividend Date
10.05.2017
Stock Valuation SAVA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
140.8451
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-8.2634
Price Book MRQ
7.139
Financials SAVA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SAVA
For 52 weeks
8.79 USD
42.2 USD
50 Day MA
22.25 USD
Shares Short Prior Month
17 677 296
200 Day MA
22.22 USD
Short Ratio
4.18
Shares Short
15 813 809
Short Percent
35.18 %
BeatStart